BDNF and myeloid sarcoma: A recent meta-analysis highlighted the potential roles of other molecular markers as well, including brain-derived neurotrophic factor (BDNF), homocysteine, vitamin B12, Tau protein, and various pro- and anti-inflammatory markers, in influencing cognitive function across the trajectory of MS.